people life enjoyment mindfulness Racing

Why I set myself the ultimate goal

Reading now: 285
www.mind.org.uk

As Big Ben struck midnight on December 31st and we ticked over into 2023, I thought long and hard about what I wanted to achieve this year.

I was hoping to push myself to complete something seemingly impossible. I decided that challenge would be to partake in raising money for charity doing something active yet different.

I explored many different options, and finally settled on the '92 in 92 Challenge'. “The opportunity to visit all stadiums in the league pyramid was something I’d enjoy along the way.”For those unfamiliar, this challenge is a race across the country in which all 92 football league clubs/stadiums (Premier league to league 2) will be visited with a selfie taken outside to prove it within a time span of 92 hours This challenge suited me because I am obsessed with football.

Read more on mind.org.uk
The website mental.guide is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.

Related articles

additudemag.com
81%
458
LSD, MDMA, Magic Mushrooms Clinical Trial Guidelines Released by FDA
July 7, 2023The Food and Drug Administration (FDA) has issued its first-ever draft guidance for clinical trials of psychedelic drugs to treat conditions including depression, mood disorders, anxiety, post-traumatic stress disorder, and substance use disorder.The guidance aims to address the unique challenges inherent in testing “classic psychedelics,” such as psilocybin (magic mushrooms) and lysergic acid diethylamide (LSD), and “entactogens” or “empathogens,” such as methylenedioxymethamphetamine (MDMA) for treating psychiatric conditions that failed to respond to other therapies. The FDA recommends clinical trial considerations regarding subject safety, data collection, manufacturing controls, and drug application requirements.Ultimately, “the goal is to help researchers design studies that will yield interpretable results that will be capable of supporting future drug applications,” said Tiffany Farchione, M.D., director of the Division of Psychiatry in the FDA’s Center for Drug Evaluation and Research, in a statement last month.In February 2022, researchers from Johns Hopkins Medicine reported that psilocybin-assisted therapy for major depressive disorder produced antidepressant effects up to 12 months after treatment.1Ari Tuckman, Psy.D., and Stephanie Sarkis, Ph.D., recently told ADDitude that using very low (micro) doses of psychedelics, such as LSD and psilocybin is gaining renewed attention as a treatment for anxiety and depression.
DMCA